1 | (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime | - | - | - | - | 1件: 161 161 |
2 | Botulism Toxin Treatment | - | - | - | - | 1件: 161 161 |
3 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: D00567
D00567
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
4 | Doxycycline | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
5 | LX3305 | - | - | - | - | 2件: 46 46, 161 |
6 | LX3305 250 mg capsule | - | - | - | - | 1件: 161 161 |
7 | None | - | - | - | - | 16件: 6 6, 46, 51, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 |
8 | SCENESSE | 1件: Afamelanotide Afamelanotide | 1件: D10511
D10511
| 1件: MC1R MC1R 💬 | 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 3件: 159 159, 161, 254 |